---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-119032"
form_type: "8-K"
ticker: "TBPH"
cik: "0001583107"
company_name: "Theravance Biopharma, Inc."
filed_at: "2025-12-08T23:59:59+00:00"
generated_at: "2026-05-16T13:58:11.089008+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "low"
source: SEC EDGAR
---

# Theravance holds ampreloxetine KOL event; AGM set for June 12, 2026

## Summary
- Virtual KOL investor event for ampreloxetine held Dec. 8, 2025; slide deck furnished as exhibit.
- 2026 Annual General Meeting scheduled for June 12, 2026 in Dublin, Ireland.
- Proxy materials will be filed with SEC and made available to shareholders prior to the meeting.

## SEC filing metadata
- accession: 0001104659-25-119032
- form_type: 8-K
- ticker: TBPH
- cik: 0001583107
- company_name: Theravance Biopharma, Inc.
- filed_at: 2025-12-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583107/000110465925119032/0001104659-25-119032-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583107/000110465925119032/tm2532919d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-119032
- JSON: https://secwatch.observer/filing/0001104659-25-119032.json
- Plain text: https://secwatch.observer/filing/0001104659-25-119032.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.